Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection — 4Us Part B  

HIV Infections Clinical Trial

Official title: Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection

Status Enrolling by invitation

Clinical Trial Summary

This randomized controlled trial evaluates the efficacy of couples HIV testing and counseling retesting. Eligible couples previously enrolled in NCT05000866 are invited to participate. Those who do are randomized to either couples HIV testing and counseling (CHTC) retesting or an individual HIV testing control. Follow-ups occur 3 and 6 months post intervention.

Clinical Trial Description

The purpose of this study is to evaluate the benefits associated with couples HIV testing and counseling (CHTC) resting. After their 12-month follow-up, those participants who remain in the same relationship they were in at the time of their baseline will be offered the opportunity to continue in the components proposed in this revision. Those who consent will be randomized to either complete a second session of CHTC or to a comparison condition in which both partners receive a routine individual HIV test. HIV positive partners in serodiscordant couples randomized to the control condition will receive information about anti-retroviral treatment adherence and U=U (undetectable = untransmissible). Given potential attrition and rates of relationship dissolution, we anticipate randomizing 200 couples (80% of the original sample). Follow-up assessments will be conducted 3 and 6 months after retesting (15 and 18 months after the participants' original baseline appointment). ;

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• Communicable Diseases
• HIV Infections
• Infections

• NCT number: NCT05833074
• Study type: Interventional
• Source: Hunter College of City University of New York
• Status: Enrolling by invitation
• Phase: N/A
• Start date: April 1, 2023
• Completion date: November 1, 2026